SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934




          Date of Report (Date of earliest event reported): May 28,1998



                             DIGITAL DICTATION, INC.
                 (Exact name of issuer as specified in charter)




                           Delaware 0-27052 52-1451022
                  (State or Other (Commission (I.R.S. Employer
                        Jurisdiction file Identification
                       of Incorporation or number) Number)
                                  Organization)



                            8230 Old Courthouse Road
                             Vienna, Virginia 22182

                    (Address of principal executive offices)


                                 (703) 848-2830
              (Registrant's telephone number, including area code)





<PAGE>



Item 1. Changes in Control of Registrant

(a)  On May 28, 1998, Transcriptions,  Ltd. ("TL"), a wholly-owned subsidiary of
     MedQuist Inc. ("MedQuist") acquired  approximately 93.4% of the outstanding
     common stock of the registrant, Digital Dictation, Inc. ("DDI") pursuant to
     an  Agreement  and  Plan of  Merger  among  MedQuist,  TL,  DDI,  Proactive
     Partners,  L.P.  ("Proactive"),  Lagunitas  Partners,  L.P.  ("Lagunitas"),
     Gruber & McBaine  International  ("G&B") and Richard D. Cameron ("Cameron")
     (the "Merger  Agreement").  Prior to the execution of the Merger Agreement,
     Proactive,  Lagunitas,  G&B  and  Cameron  (collectively,   the  "Principal
     Shareholders")  owned 5,908,673  shares of DDI common stock, par value $.01
     per share ("DDI Common Stock"),  or approximately  93.4% of the outstanding
     shares of DDI Common Stock.  Pursuant to the Merger  Agreement,  on May 28,
     1998 the  Principal  Shareholders  exchanged  each of their  shares  of DDI
     Common Stock for 0.0720449  shares of MedQuist  common stock,  no par value
     per share  ("MedQuist  Common  Stock"),  for a total of  425,688  shares of
     MedQuist  Common  Stock.  In  connection  with the  execution of the Merger
     Agreement,  the executive  officers and directors of DDI resigned,  and the
     current  executive  officers  and  directors  of TL, as  identified  on the
     Schedule 13D filed by MedQuist and TL on June 8, 1998, became the executive
     officers and directors of DDI. 

     Moreover, pursuant to the Merger Agreement, DDI will merge with and into TL
     (the "Merger")  upon the effectiveness of a Registration  Statement on Form
     S-4 covering  shares of MedQuist Common  Stock to be  issued in the Merger,
     with TL being the surviving corporation of the merger. Upon consummation of
     the Merger, the holders of DDI Common Stock, other  than TL,  will  receive
     0.0720449 shares of MedQuist Common Stock in exchange for each share of DDI
     Common Stock held by such stockholders. Outstanding options to purchase DDI
     Common  Stock  will be  exchanged  on an  equivalent  basis for  options to
     purchase  MedQuist  Common  Stock.  MedQuist  Common Stock is traded on the
     Nasdaq  National  Market  under  the  symbol  "MEDQ."  MedQuist's  and TL's
     executive  offices are located at Five Greentree  Centre Suite 311 Marlton,
     New Jersey 08053. 

Item 7. Exhibits.  

(c)  The Merger Agreement  described in Item 1 above was filed with the Schedule
     13D filed by MedQuist and TL on June 8, 1998, and is incorporated herein by
     reference. 

<PAGE>

                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                     DIGITAL DICTATION, INC.


Date:  June 12, 1998                 By:     /s/ John M. Suender
                                           -----------------------
                                     Name:    John M. Suender
                                     Title:   Vice President and General Counsel


<PAGE>
[{"type": "8-K", "sequence": "1", "description": "CURRENT REPORT", "secsgml_size_bytes": 4342}]
{"company-data": {"conformed-name": "DIGITAL DICTATION INC", "cik": "0001002665", "assigned-sic": "7371", "irs-number": "521451022", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27052", "film-number": "98646907"}, "business-address": {"street1": "8230 OLD COURTHOUSE RD", "street2": "STE 100", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7038482830"}, "mail-address": {"street1": "8230 OLD COURTHOUSE RD", "street2": "STE 100", "city": "VIENNA", "state": "VA", "zip": "22182"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

          Date of Report (Date of earliest event reported): May 28,1998

                             DIGITAL DICTATION, INC.
                 (Exact name of issuer as specified in charter)

                           Delaware 0-27052 52-1451022
                  (State or Other (Commission (I.R.S. Employer
                        Jurisdiction file Identification
                       of Incorporation or number) Number)
                                  Organization)

                            8230 Old Courthouse Road
                             Vienna, Virginia 22182

                    (Address of principal executive offices)

                                 (703) 848-2830
              (Registrant's telephone number, including area code)
Item 1. Changes in Control of Registrant

(a)  On May 28, 1998, Transcriptions,  Ltd. ("TL"), a wholly-owned subsidiary of
     MedQuist Inc. ("MedQuist") acquired  approximately 93.4% of the outstanding
     common stock of the registrant, Digital Dictation, Inc. ("DDI") pursuant to
     an  Agreement  and  Plan of  Merger  among  MedQuist,  TL,  DDI,  Proactive
     Partners,  L.P.  ("Proactive"),  Lagunitas  Partners,  L.P.  ("Lagunitas"),
     Gruber & McBaine  International  ("G&B") and Richard D. Cameron ("Cameron")
     (the "Merger  Agreement").  Prior to the execution of the Merger Agreement,
     Proactive,  Lagunitas,  G&B  and  Cameron  (collectively,   the  "Principal
     Shareholders")  owned 5,908,673  shares of DDI common stock, par value $.01
     per share ("DDI Common Stock"),  or approximately  93.4% of the outstanding
     shares of DDI Common Stock.  Pursuant to the Merger  Agreement,  on May 28,
     1998 the  Principal  Shareholders  exchanged  each of their  shares  of DDI
     Common Stock for 0.0720449  shares of MedQuist  common stock,  no par value
     per share  ("MedQuist  Common  Stock"),  for a total of  425,688  shares of
     MedQuist  Common  Stock.  In  connection  with the  execution of the Merger
     Agreement,  the executive  officers and directors of DDI resigned,  and the
     current  executive  officers  and  directors  of TL, as  identified  on the
     Schedule 13D filed by MedQuist and TL on June 8, 1998, became the executive
     officers and directors of DDI. 

     Moreover, pursuant to the Merger Agreement, DDI will merge with and into TL
     (the "Merger")  upon the effectiveness of a Registration  Statement on Form
     S-4 covering  shares of MedQuist Common  Stock to be  issued in the Merger,
     with TL being the surviving corporation of the merger. Upon consummation of
     the Merger, the holders of DDI Common Stock, other  than TL,  will  receive
     0.0720449 shares of MedQuist Common Stock in exchange for each share of DDI
     Common Stock held by such stockholders. Outstanding options to purchase DDI
     Common  Stock  will be  exchanged  on an  equivalent  basis for  options to
     purchase  MedQuist  Common  Stock.  MedQuist  Common Stock is traded on the
     Nasdaq  National  Market  under  the  symbol  "MEDQ."  MedQuist's  and TL's
     executive  offices are located at Five Greentree  Centre Suite 311 Marlton,
     New Jersey 08053. 

Item 7. Exhibits.  

(c)  The Merger Agreement  described in Item 1 above was filed with the Schedule
     13D filed by MedQuist and TL on June 8, 1998, and is incorporated herein by
     reference.
SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                     DIGITAL DICTATION, INC.

Date:  June 12, 1998                 By:     /s/ John M. Suender
                                           -----------------------
                                     Name:    John M. Suender
                                     Title:   Vice President and General Counsel